2-2--azino-di-(3-ethylbenzothiazoline)-6-sulfonic-acid and Liver-Diseases

Farsetia hamiltonii Royle, also known as Hiran Chabba grows in desert regions. It is widely used as folk medicine to treat joint pains, diarrhea and diabetes. However, its antioxidant and iron chelation abilities both in vitro and in vivo have not yet been investigated.. The 70% methanolic extract of F. hamiltonii (FHME) was investigated for its free radical scavenging and iron chelation potential, in vitro. An iron-overload situation was established by intraperitoneal injection of iron-dextran in Swiss albino mice, followed by oral administration of FHME. Liver damage and serum parameters due to iron-overload were measured biochemically and histopathologically to test iron-overload remediation and hepatoprotective potential of FHME. Phytochemical analyses were performed to determine its probable bioactive components.. FHME showed promising antioxidant activity, scavenged various reactive oxygen and nitrogen species and chelated iron in vitro. FHME reduced liver iron, serum ferritin, normalized serum parameters, reduced oxidative stress in liver, serum and improved liver antioxidant status in ironoverloaded mice. It also alleviated liver damage and fibrosis as evident from biochemical parameters and morphological analysis of liver sections. The phytochemical analyses of FHME reflected the presence of alkaloids, phenols, flavonoids and tannins. HPLC analysis indicated presence of tannic acid, quercetin, methyl gallate, catechin, reserpine, ascorbic acid and gallic acid.. Based on the experimental outcome, FHME, an ethnologically important plant can be envisaged as excellent antioxidant and iron chelator drug capable of remediating iron-overload induced hepatotoxicity and the bioactive compounds present in FHME might be responsible for its efficacy.

Topics: Animals; Antioxidants; Benzothiazoles; Brassicaceae; Iron; Iron Chelating Agents; Iron Overload; Liver; Liver Diseases; Male; Mice; Phytochemicals; Plant Extracts; Reactive Nitrogen Species; Reactive Oxygen Species; Sulfonic Acids

A new method for the determination of xanthine oxidase activity, based on the oxidation of 2,2'-azino-di(3-ethylbenzthiazoline-6-sulphonate) (ABTS) by use of uricase and peroxidase, is described. The absorbance increase of the oxidized form of ABTS, measured after 10 min at 410 nm is proportional to xanthine oxidase activity. The method is sensitive, precise (CV below 8.3%), and linear up to 20 U/l. The analytical recovery of the ABTS-method was quantitative. Comparison with the UV and colorimetric NBT-method gave good correlation (r greater than or equal to 0.984). Reference values for serum xanthine oxidase activities determined with the new ABTS-method on 83 healthy persons are 0 to 1.20 U/l.

Topics: Adolescent; Adult; Benzothiazoles; Chromogenic Compounds; Female; Humans; Liver; Liver Diseases; Male; Middle Aged; Reference Values; Spectrophotometry; Sulfonic Acids; Xanthine Oxidase

A simple spectrophotometric assay for serum guanase based on the oxidation of 2,2'-azino-di(3-ethylbenzthiazoline-6-sulphate) (ABTS) using xanthine oxidase, uricase and peroxidase is described and statistically examined through its application to normal and pathological sera. The method is very sensitive, precise (CV below 8.13%) and linear up to 152.5 U/l. Comparison with the methods of Hue & Free ((1965) Clin. Chem. 11, 708-715), and Giusti ((1974) In: Methods of Enzymatic Analysis, Bergmeyer, H. U., ed., p. 1086), and Ito et al. ((1981) Clin. Chim. Acta 115, 135-144) gave a good correlation (r greater than or equal to 0.969). The reference values for the ABTS-method are 2.93 to 23.92 U/l (mean = 13.57 U/l, CV = 22.43%). The mean values of guanase activities determined in sera of patients with different liver diseases (mean = 30.29 U/l), or chronic alcoholics (mean = 35.41 U/l) were significantly higher than normal. The patients with chronic diseases had significantly lower activity (mean = 7.22 U/l, t = 9.25, p less than 0.001).

Topics: Alcoholism; Aminohydrolases; Benzothiazoles; Guanine Deaminase; Humans; Kidney Diseases; Liver Diseases; Sulfonic Acids